Dashboard
Manage Tickers

AVDL


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lundbecks-higher-buyout-proposal-challenges-alkermes-pending-2-billion-avadel-deal
Lundbeck's Higher Buyout Proposal Challeng...
11/14/2025 16:37:57

Avadel reviews Lundbeck's unsolicited $23 offer while maintaining its agreement with Alkermes as its board evaluates whethe...

legence-cidara-therapeutics-avadel-pharmaceuticals-omeros-and-other-big-stocks-moving-higher-on-friday
Legence, Cidara Therapeutics, Avadel Pharm...
11/14/2025 14:54:48

Core News & Articles
Alkermes Says It Is Considering Options Af...
11/14/2025 12:47:54

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/14/2025 12:06:17

Core News & Articles
Avadel Board Says Lundbeck Proposal May Be...
11/14/2025 10:51:53

Core News & Articles
Avadel Receives Unsolicited Lundbeck Propo...
11/14/2025 10:51:23

wells-fargo-maintains-equal-weight-on-avadel-pharmaceuticals-raises-price-target-to-20
Wells Fargo Maintains Equal-Weight on Avad...
11/07/2025 18:48:38

Wells Fargo analyst Benjamin Burnett maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Equal-Weight and raises the price...

avadel-pharmaceuticals-q3-eps-000-misses-007-estimate-sales-77467m-beat-73574m-estimate
Avadel Pharmaceuticals Q3 EPS $0.00 Misses...
11/04/2025 21:37:47

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate...

ubs-downgrades-avadel-pharmaceuticals-to-neutral-maintains-price-target-to-20
UBS Downgrades Avadel Pharmaceuticals to N...
10/28/2025 11:51:44

UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Neutral and maintains the price target...

deal-dispatch-from-four-roses-bourbon-to-quantum-stakes-here-are-this-weeks-sector-shake-ups
Deal Dispatch: From Four Roses Bourbon To ...
10/24/2025 16:20:19

Four Roses, Six Flags, and Trump's potential Quantum investments: This week's deal activity involves big bets across va...

leerink-partners-downgrades-avadel-pharmaceuticals-to-market-perform-announces-185-price-target
Leerink Partners Downgrades Avadel Pharmac...
10/23/2025 21:52:33

Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Outperform to Market Perform and ...

tesla-to-rally-more-than-16-here-are-10-top-analyst-forecasts-for-thursday
Tesla To Rally More Than 16%? Here Are 10 ...
10/23/2025 12:48:03

this-winnebago-industries-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday
This Winnebago Industries Analyst Is No Lo...
10/23/2025 12:32:36

hc-wainwright--co-downgrades-avadel-pharmaceuticals-to-neutral-lowers-price-target-to-20
HC Wainwright & Co. Downgrades Avadel Phar...
10/23/2025 11:59:05

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Neutral and l...

alkermes-strikes-21-billion-avadel-deal-gains-access-to-narcolepsy-drug-lumryz
Alkermes Strikes $2.1 Billion Avadel Deal,...
10/22/2025 19:18:55

Alkermes agrees to acquire Avadel for $2.1 billion, adding the successful Lumryz drug and accelerating entry into sleep medicin...

beyond-the-numbers-5-analysts-discuss-avadel-pharmaceuticals-stock
Beyond The Numbers: 5 Analysts Discuss Ava...
10/22/2025 18:00:44

jefferies-downgrades-avadel-pharmaceuticals-to-hold-lowers-price-target-to-20
Jefferies Downgrades Avadel Pharmaceutical...
10/22/2025 16:07:34

Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold and lowers the price target f...

needham-downgrades-avadel-pharmaceuticals-to-hold
Needham Downgrades Avadel Pharmaceuticals ...
10/22/2025 14:37:20

Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold.

trading-halt-halt-status-updated-at-71500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:15:...
10/22/2025 11:15:04

Core News & Articles
Alkermes To Acquire Avadel Pharmaceuticals...
10/22/2025 11:14:36

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION